Skip to content

CorMedix CRMD Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$181.01M+11.0%$163.06M
$11.06M+1,534%$677K+45.7%$464.69K+41.6%$328.24K+11.6%$294.17K+91.0%
$14.91M+7.8%$13.83M+20.9%$11.44M+33.0%$8.6M+19.7%$7.18M+17.2%
$197.69M+12.9%$175.05M+133%$74.97M+146%$30.46M+325%-$13.57M+73.2%
$2.98M+31.8%$2.26M+311%$550.04K+918%$54.03K-16.5%$64.69K-44.2%
-$308.57M+1.0%-$311.73M0.0%-$311.73M-2,113%-$14.09M-214%$12.39M-42.4%
$221.68M-7.6%$239.87M-4.5%$251.15M+119%$114.69M+253%$32.51M+23.5%
$194.71M+12.7%$172.79M+132%$74.42M+145%$30.41M+323%-$13.63M+73.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does CorMedix generate?
CorMedix (CRMD) generated $197.7M in operating cash flow over the trailing twelve months.
What is CorMedix's free cash flow?
After $3.0M of capital expenditures, CorMedix's free cash flow was $194.7M over the trailing twelve months, up 1528.3% year over year.
Where does CorMedix's cash flow data come from?
Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.